Insights

Updating results

Showing results 1 - 24 of 585 Results per page:

No results found.

  • Advertising, Marketing & Regulatory
  • Artificial Intelligence
  • Automotive
  • Cannabis
  • Chemical
  • Chemical AI
  • Cleantech
  • Copyright & Digital Media
  • Electrical & Computer Technology
  • Financial Technology
  • Industrial Designs
  • IP Management & Strategic Counselling
  • Licensing & Transactions
  • Life Sciences
  • Litigation & Dispute Resolution
  • Mechanical & Industrial Processes
  • Medical Technology
  • Nanotechnology
  • Oil & Gas
  • Patents
  • Plant Breeders’ Rights
  • Privacy & Data Protection
  • Psychedelics
  • Quantum Technologies
  • Trademarks
  • Nicholas Aitken
  • Arvin Angue
  • Adam Aucoin
  • William Audet
  • Ryan Baker
  • Christie J. C. Bates
  • Stephen Beney
  • Brett Benham
  • Daniel Bereskin
  • Janice M. Bereskin
  • Shaivi Bhatt
  • Adam Bierylo
  • Paul David Blizzard
  • Adam Bobker
  • Jennifer Boothby
  • Chantalle Briggs
  • Jonathan G. Burkinshaw
  • Don Cameron
  • Isi Caulder
  • Brigitte Chan
  • Wynnie Chan
  • Mina Chana
  • Herman Cheung
  • Iris Cheung
  • Kyle Classen
  • Toba Cooper
  • Noel Courage
  • Carmela De Luca
  • Ryan De Vries
  • Reshika Dhir
  • Meghan Dillon
  • Terry Edwards
  • Prudence Ariella Etkin
  • Michael Fenwick
  • Patricia Folkins
  • Cameron Gale
  • Matthew John Graff
  • Louis-Pierre Gravelle
  • Micheline Gravelle
  • Gail Hung
  • Nicole Hunter
  • Jason Hynes
  • Alissa Hyppolite
  • Nyrie Israelian
  • Susan J. Keri
  • Denis V. Keseris
  • Ellen Kiernan
  • Simone Knott
  • Ray Kovarik
  • Victor Krichker
  • Dominique Lambert
  • François Larose
  • Julia London
  • Maddie Lynch
  • Joanna Ma
  • R. Scott MacKendrick
  • Don MacOdrum
  • Jennifer Manley
  • Sandra Marone
  • Andrew McIntosh
  • Melissa J. McKeon
  • Ian McMillan
  • Philip C. Mendes da Costa
  • Hailey Min
  • David Morrison
  • Luba Naiberger
  • Paige Newman
  • Andrea Ngo
  • Tony Orsi
  • Ainslie Parsons
  • Chelsea Pham
  • Justin Philpott
  • Scott Pundsack
  • James Raakman
  • Mohamed Rahal
  • Bhupinder Randhawa
  • Sunil Rao
  • Kimberly Ren
  • Coralee Ridder
  • Mark L. Robbins
  • Jane Sargeant
  • Timothy Sinnott
  • Parnian Soltanipanah
  • Josh Spicer
  • David St-Martin
  • Kate Stewart-Tiralongo
  • Robert Storey
  • Jessica R. Sudbury
  • Melanie Szweras
  • Benjamin Todd
  • Andrea Uetrecht
  • Charles Wang
  • Maria Wei
  • Tamara Céline Winegust
  • Shuo Xing
  • Leanne Young
  • Jennie Yum
  • Previous 30 days
  • Previous 90 days
  • Previous year
  • From to

Explore our Insights

February 10, 2023
2022 Year in Review: Cleantech
By Ellen Kiernan, Justin Philpott, and Matthew Graff
February 7, 2023
Charter of the French Language: Reality Check on Bill 96 and its Impacts on Trademark Use in Québec
By François Larose
February 1, 2023
2022 Year in Review: Key Trademark Cases in Canada
By Susan J. Keri, Mark L. Robbins, Meghan Dillon, 
January 26, 2023
2022 Year in Review: Electrical & Computer Technology
By Reshika Dhir and Andrea Ngo
January 17, 2023
2022 Year in Review: Canadian Copyright
By: Adam Bobker, François Larose, Prudence Etkin, Adam Aucoin, Julia London, and Siobhan Doody
January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection
By Maddie Lynch and Melanie Szweras
January 12, 2023
Significant Changes to the European Patent System Are Coming in 2023 – Here is What Canadian Applicants Need to Know
By Denis V. Keseris and Ellen Kiernan
January 10, 2023
Canadian Grant Agency Raises Clinical Trial Reporting Requirements
By Maddie Lynch and Noel Courage 
December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!
By Melanie Szweras and Chantalle Briggs
December 15, 2022
Preparing the Expert Report in a Patent Case – A Collaborative Exercise to be Approached with Caution
By Adam Bobker
December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
By Noel Courage and Maddie Lynch
December 9, 2022
Crocs’ Design Takes a Bite Out of the Competition
By Matthew Graff and Ellen Kiernan

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

December 6, 2022
Skating to Where the Puck Is Going to Be – How the IRAP ‘IP Assist’ Program Can Help With Startup Business Goals
December 2, 2022
The Role of IP Management in Product Development
By Luba Naiberger and Noel Courage 
November 25, 2022
IP, Digital Identity, and Branding in the Metaverse and Web3 – Part I: Digital Identity and the Creator Economy
By Wynnie Chan and Callum Lootsma 
November 24, 2022
Order Vacated; Order Restored—BOMBAY FRANKIE Injunction Appeal Allowed
By Tamara Céline Winegust, Siobhan Doody, and R. Scott MacKendrick
November 24, 2022
70 Is the New 50: Term of Copyright Protection in Canada to Become “Life Plus 70” on December 30, 2022
By François Larose and Adam Aucoin
November 16, 2022
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims
By: Melanie Szweras, Ian McMillan, and Nicole LaBerge
November 10, 2022
PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued
By Nyrie Israelian, Parnian Soltanipanah, Melanie Szweras, Noel Courage 
November 2, 2022
IP Metaverse Series – Part IV: Pitching Metaverse Advertising in Canada – Opportunities and Legal Considerations
By Wynnie Chan, Prudence Etkin
October 21, 2022
United States Court of Appeals for the Federal Circuit Holds That an Artificial Intelligence System Cannot Be an Inventor on a Patent Application
By Bhupinder Randhawa, Ray Kovarik and Leanne Young.
September 26, 2022
Form II: Anticipation and Obviousness of Crystal Form Patents in the Federal Court of Canada
By Joshua W. Spicer and Bruna D.D. Kalinoski 
September 23, 2022
Class certification for privacy breaches, not so easy to come by
By Melanie Szweras, Parnian Soltanipanah and William Audet
August 26, 2022
Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy
By Noel Courage and Iris Cheung
Loading...

Showing results 1 - 24 of 585 Results per page:

No results found.

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on wpml.org as a development site.